FDA Approves First Generic Copaxone in Multiple SclerosisFDA Approves First Generic Copaxone in Multiple Sclerosis

A generic version of the standard MS therapy glatiramer acetate receives FDA approval. FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news